1 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Ceftriaxone for Injection: new trials by email Literature Review of Ceftriaxone for Injection trials Research Report on Ceftriaxone for Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection | Phase 2 | Not yet recruiting | The University of Queensland | 300 | 2027-04-01 | 2026-03-20 |
| Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP Ampicillin for Injection, Ceftriaxone for Injection, Amoxicillin - Community Acquired Pneumonia in Children | Phase 4 | Recruiting | Medical College of Wisconsin | 236 | 2024-08-22 | 2026-03-02 |
Community-Acquired Pneumonia (1) · Infections (1) · Mycobacterium Infections, Nontuberculous (1)
Medical College of Wisconsin (1) · The University of Queensland (1)
United States (1)